CVS Health Corporation (CVS) - Financials, balance sheet (annual)

59.62000 USD

Last update May 29, 10:21 AM -04

Market closed

Day range

59.62000

Previous close

59.62000

Open

59.62000

Access this stock data via API

CVS Health Corporation

59.62

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	253.2B	249.7B	228.3B	233.0B
Current assets	68.6B	67.9B	65.6B	60.0B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	8.6B	8.2B	12.9B	9.4B
Other short term investments	2.4B	3.3B	2.8B	3.1B
Accounts receivable	14.6B	15.6B	11.7B	10.5B
Other receivables	21.9B	19.6B	15.6B	14.0B
Inventory	18.1B	18.0B	19.1B	17.8B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	0	908M	0
Hedging assets	—	—	—	—
Other current assets	3.1B	3.2B	2.6B	5.3B
Non current assets	184.6B	181.9B	162.6B	173.0B
Properties	15.9B	17.3B	17.6B	19.1B
Land and improvements	1.8B	2.0B	2.0B	2.0B
Machinery furniture equipment	23.2B	20.8B	21.8B	21.0B
Construction in progress	—	—	—	—
Leases	6.7B	6.5B	6.2B	6.2B
Accumulated depreciation	-23.4B	-20.7B	-21.5B	-20.7B
Goodwill	209.9B	211.8B	181.1B	187.3B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	27.3B	29.2B	24.8B	29.0B
Investments and advances	28.9B	23.0B	21.1B	23.0B
Other non current assets	4.8B	4.7B	4.6B	4.7B
Total liabilities	177.5B	173.1B	156.5B	157.6B
Current liabilities	84.6B	79.2B	69.4B	67.8B
Accounts payable	15.9B	14.9B	14.8B	12.5B
Accrued expenses	20.8B	23.5B	18.7B	17.7B
Short term debt	7.5B	4.7B	3.5B	5.9B
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	1.2B	1.1B	2.8B	5.6B
Non current liabilities	92.9B	93.9B	87.1B	89.8B
Long term provisions	—	—	—	—
Long term debt	75.4B	74.7B	67.3B	70.1B
Provision for risks and charges	—	—	—	—
Deferred liabilities	3.8B	4.3B	4.0B	6.3B
Derivative product liabilities	—	—	—	—
Other non current liabilities	10.3B	11.7B	12.6B	8.3B
Shareholders equity
Common stock	49.7B	49.0B	48.2B	47.4B
Retained earnings	62.8B	61.6B	56.4B	54.9B
Other shareholders equity	-120M	-297M	-1.3B	965M
Total shareholders equity	75.7B	76.6B	71.8B	75.4B
Additional paid in capital	—	—	—	—
Treasury stock	36.8B	33.8B	31.9B	28.2B
Minority interest	170M	175M	300M	306M